These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27678372)

  • 1. The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms.
    Guo ZL; Richardson DR; Kalinowski DS; Kovacevic Z; Tan-Un KC; Chan GC
    J Hematol Oncol; 2016 Sep; 9(1):98. PubMed ID: 27678372
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Xu YX; Zeng ML; Yu D; Ren J; Li F; Zheng A; Wang YP; Chen C; Tao ZZ
    Oncol Lett; 2018 May; 15(5):7999-8004. PubMed ID: 29740495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents.
    Sestak V; Stariat J; Cermanova J; Potuckova E; Chladek J; Roh J; Bures J; Jansova H; Prusa P; Sterba M; Micuda S; Simunek T; Kalinowski DS; Richardson DR; Kovarikova P
    Oncotarget; 2015 Dec; 6(40):42411-28. PubMed ID: 26623727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thiosemicarbazone, DpC, broadly synergizes with multiple anti-cancer therapeutics and demonstrates temperature- and energy-dependent uptake by tumor cells.
    Dharmasivam M; Azad MG; Afroz R; Richardson V; Jansson PJ; Richardson DR
    Biochim Biophys Acta Gen Subj; 2022 Aug; 1866(8):130152. PubMed ID: 35436509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc.
    Wijesinghe TP; Dharmasivam M; Dai CC; Richardson DR
    Pharmacol Res; 2021 Nov; 173():105889. PubMed ID: 34536548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC.
    Seebacher NA; Richardson DR; Jansson PJ
    Cell Death Dis; 2016 Dec; 7(12):e2510. PubMed ID: 27906178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion.
    Lui GY; Kovacevic Z; V Menezes S; Kalinowski DS; Merlot AM; Sahni S; Richardson DR
    Mol Pharmacol; 2015; 87(3):543-60. PubMed ID: 25561562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect.
    Quach P; Gutierrez E; Basha MT; Kalinowski DS; Sharpe PC; Lovejoy DB; Bernhardt PV; Jansson PJ; Richardson DR
    Mol Pharmacol; 2012 Jul; 82(1):105-14. PubMed ID: 22508546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer.
    Shehadeh-Tout F; Milioli HH; Roslan S; Jansson PJ; Dharmasivam M; Graham D; Anderson R; Wijesinghe T; Azad MG; Richardson DR; Kovacevic Z
    Pharmacol Res; 2023 Jul; 193():106806. PubMed ID: 37244387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy.
    Fang BA; Kovačević Ž; Park KC; Kalinowski DS; Jansson PJ; Lane DJ; Sahni S; Richardson DR
    Biochim Biophys Acta; 2014 Jan; 1845(1):1-19. PubMed ID: 24269900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms.
    Paukovcekova S; Skoda J; Neradil J; Mikulenkova E; Chlapek P; Sterba J; Richardson DR; Veselska R
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33334021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SPME fibers based on a plastic support for determination of plasma protein binding of thiosemicarbazone metal chelators: a case example of DpC, an anti-cancer drug that entered clinical trials.
    Reimerová P; Stariat J; Bavlovič Piskáčková H; Jansová H; Roh J; Kalinowski DS; Macháček M; Šimůnek T; Richardson DR; Štěrbová-Kovaříková P
    Anal Bioanal Chem; 2019 Apr; 411(11):2383-2394. PubMed ID: 30820631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).
    Gutierrez EM; Seebacher NA; Arzuman L; Kovacevic Z; Lane DJ; Richardson V; Merlot AM; Lok H; Kalinowski DS; Sahni S; Jansson PJ; Richardson DR
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1665-81. PubMed ID: 27102538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, DpC, using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
    Stariat J; Kovaříková P; Kučera R; Klimeš J; Kalinowski DS; Richardson DR; Ketola RA
    Anal Bioanal Chem; 2013 Feb; 405(5):1651-61. PubMed ID: 23180090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo.
    Li P; Zheng X; Shou K; Niu Y; Jian C; Zhao Y; Yi W; Hu X; Yu A
    Am J Transl Res; 2016; 8(12):5370-5385. PubMed ID: 28078009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing Tailored Thiosemicarbazones with Bespoke Properties: The Styrene Moiety Imparts Potent Activity, Inhibits Heme Center Oxidation, and Results in a Novel "Stealth Zinc(II) Complex".
    Dharmasivam M; Kaya B; Wijesinghe T; Gholam Azad M; Gonzálvez MA; Hussaini M; Chekmarev J; Bernhardt PV; Richardson DR
    J Med Chem; 2023 Jan; 66(2):1426-1453. PubMed ID: 36649565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells.
    Krchniakova M; Paukovcekova S; Chlapek P; Neradil J; Skoda J; Veselska R
    Front Pharmacol; 2022; 13():976955. PubMed ID: 36160437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer.
    Kovacevic Z; Chikhani S; Lovejoy DB; Richardson DR
    Mol Pharmacol; 2011 Oct; 80(4):598-609. PubMed ID: 21719465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy.
    Yu Y; Suryo Rahmanto Y; Richardson DR
    Br J Pharmacol; 2012 Jan; 165(1):148-66. PubMed ID: 21658021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular uptake of the antitumor agent Dp44mT occurs via a carrier/receptor-mediated mechanism.
    Merlot AM; Pantarat N; Menezes SV; Sahni S; Richardson DR; Kalinowski DS
    Mol Pharmacol; 2013 Dec; 84(6):911-24. PubMed ID: 24085840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.